Home/AI Proteins/Ben Meinen, MS, PhD

BM

Ben Meinen, MS, PhD

Investigator, Head of Protein Design

Therapeutic Areas

Immunology & Inflammation Oncology Metabolic

AI Proteins Pipeline

Drug	Indication	Phase
TNFR1 Antagonist	Immunology & Inflammation	Discovery
Undisclosed Immune Activator	Oncology	Discovery
Undisclosed Targeted Radiotherapy	Oncology	Discovery
Undisclosed Program 1 (BMS)	Undisclosed	Discovery
Undisclosed Program 2 (BMS)	Undisclosed	Discovery

Leadership Team at AI Proteins

Chris Bahl, MS, PhD

President, Chief Executive Officer, Founder

Alyssa Anderson, PhD

Investigator, Head of Protein Characterization

Arturo Vera Rodriguez, MS, PhD

Senior Investigator, Head of Bioprocess Development

View full AI Proteins profile